BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 29, 2021
View Archived Issues
Chengdu Baiyu Pharmaceutical presents new tetrahydrocannabinol derivatives
Read More
New RORgammaT agonists identified at Sunshine Lake Pharma
Read More
Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent PD-1/PD-L1 inhibitors
Read More
First patients dosed in new studies of Xpovio in melanoma and myelofibrosis
Read More
FDA authorizes phase II study of autologous adipose-derived mesenchymal stem cells in MS
Read More
Vonafexor meets primary endpoint in the phase IIa LIVIFY study in patients with NASH
Read More
New serine-protein kinase ATM inhibitors described by Medshine Discovery
Read More
ISIS-814907 well tolerated in first-in-human study in mild Alzheimer's disease patients
Read More
MMV-688533 shows excellent single-dose efficacy in P. falciparum-infected mouse model
Read More
Selinexor shows antiviral and the anti-inflammatory effects in models of SARS-CoV-2 infection
Read More
Phase II study of CETP inhibitor obicetrapib meets primary endpoint
Read More
IDMC of phase II study of EscharEx for venous leg ulcers recommends continuation of trial
Read More
Targeting the IL-8/CXCR2 axis as a potential therapeutic strategy in prostate cancer
Read More
New phase Ib/II trial evaluates pembrolizumab combination therapies in second-line ES-SCLC
Read More
Venatorx reports phase I data on beta-lactamase inhibitor VNRX-7145
Read More
Arcturus cleared to begin phase II study of ARCT-810 for OTC deficiency
Read More
Clarity initiates phase I/IIa theranostic trial of 64/67Cu SAR-bisPSMA in metastatic CRPC
Read More
Restoring chondroitin 6-sulfate can rescue age-related memory impairment
Read More
Daewoong reports phase IIb topline data on Foistar in mild COVID-19
Read More
FDA clears INDs for targeted alpha therapy FPI-1966 and imaging agent FPI-1967
Read More
Blueprint Medicines and MD Anderson collaborate on advancing CDK2 inhibitor BLU-222
Read More
